124 related articles for article (PubMed ID: 11908998)
21. Identification of a novel biomarker gene set with sensitivity and specificity for distinguishing between allograft rejection and tolerance.
Xie L; Ichimaru N; Morita M; Chen J; Zhu P; Wang J; Urbanellis P; Shalev I; Nagao S; Sugioka A; Zhong L; Nonomura N; Takahara S; Levy GA; Li XK
Liver Transpl; 2012 Apr; 18(4):444-54. PubMed ID: 22162188
[TBL] [Abstract][Full Text] [Related]
22. Variations in DNA methylation of interferon gamma and programmed death 1 in allograft rejection after kidney transplantation.
Boer K; de Wit LE; Peters FS; Hesselink DA; Hofland LJ; Betjes MG; Looman CW; Baan CC
Clin Epigenetics; 2016; 8():116. PubMed ID: 27891189
[TBL] [Abstract][Full Text] [Related]
23. Risk of adverse post-transplant events after kidney allograft transplantation as predicted by CTLA-4 +49 and TNF-alpha -308 single nucleotide polymorphisms: a preliminary study.
Gendzekhadze K; Rivas-Vetencourt P; Montano RF
Transpl Immunol; 2006 Nov; 16(3-4):194-9. PubMed ID: 17138053
[TBL] [Abstract][Full Text] [Related]
24. Proteasome inhibitor treatment of antibody-mediated allograft rejection.
Woodle ES; Alloway RR; Girnita A
Curr Opin Organ Transplant; 2011 Aug; 16(4):434-8. PubMed ID: 21753709
[TBL] [Abstract][Full Text] [Related]
25. T cell costimulation blockade and organ transplantation: a change of philosophy for transplant immunologists?
Goldstein DR
J Immunol; 2011 Mar; 186(5):2691-2. PubMed ID: 21325217
[No Abstract] [Full Text] [Related]
26. Cytokines as predictive biomarkers of alloreactivity.
Brunet M
Clin Chim Acta; 2012 Sep; 413(17-18):1354-8. PubMed ID: 22561186
[TBL] [Abstract][Full Text] [Related]
27. Association between IL-4 polymorphism and acute rejection of solid organ allograft: a meta-analysis.
Wu W; Liu Y; Li S; Hu L; Sun X; Cai L; Gong G
Gene; 2013 Jan; 513(1):14-21. PubMed ID: 23107766
[TBL] [Abstract][Full Text] [Related]
28. Messengers of tolerance.
Bontha SV; Fernandez-Piñeros A; Maluf DG; Mas VR
Hum Immunol; 2018 May; 79(5):362-372. PubMed ID: 29402484
[TBL] [Abstract][Full Text] [Related]
29. Transplantation: tolerance.
Hutchings A; Thomas JM
Curr Opin Investig Drugs; 2003 May; 4(5):530-5. PubMed ID: 12833645
[TBL] [Abstract][Full Text] [Related]
30. T-Cell Cytokines as Predictive Markers of the Risk of Allograft Rejection.
Brunet M; Millán López O; López-Hoyos M
Ther Drug Monit; 2016 Apr; 38 Suppl 1():S21-8. PubMed ID: 26444655
[TBL] [Abstract][Full Text] [Related]
31. Analysis of cytokine gene polymorphisms in recipient's matched with living donors on acute rejection after renal transplantation.
Manchanda PK; Mittal RD
Mol Cell Biochem; 2008 Apr; 311(1-2):57-65. PubMed ID: 18165865
[TBL] [Abstract][Full Text] [Related]
32. Study of the relationships between IL-23R, IL-17, IL-21 polymorphisms and serum level of IL-17, IL-21 with acute graft rejection in iranian liver transplant recipients.
Karimi MH; Hejr S; Geramizadeh B; Nikeghbalian S; Kamali-Sarvestani E; Yaghobi R
Immunol Invest; 2014; 43(1):69-85. PubMed ID: 24313807
[TBL] [Abstract][Full Text] [Related]
33. The relationship between interferon-γ gene polymorphism and acute kidney allograft rejection.
Zibar L; Wagner J; Pavlinić D; Galić J; Pasini J; Juras K; Barbić J
Scand J Immunol; 2011 Apr; 73(4):319-24. PubMed ID: 21204904
[TBL] [Abstract][Full Text] [Related]
34. Identification of high and low responders to allografts.
Hutchinson IV; Pravica V; Hajeer A; Sinnott PJ
Rev Immunogenet; 1999; 1(3):323-33. PubMed ID: 11256423
[TBL] [Abstract][Full Text] [Related]
35. Pharmacogenetics of immunosuppressive drugs: prospect of individual therapy for transplant patients.
Ekbal NJ; Holt DW; Macphee IA
Pharmacogenomics; 2008 May; 9(5):585-96. PubMed ID: 18466104
[TBL] [Abstract][Full Text] [Related]
36. Effect of donor tumor necrosis factor-alpha and interleukin-10 genotypes on delayed graft function and acute rejection in kidney transplantation.
Mandegary A; Azmandian J; Soleymani S; Pootari M; Habibzadeh SD; Ebadzadeh MR; Dehghani-Firouzabadi MH
Iran J Kidney Dis; 2013 Mar; 7(2):135-41. PubMed ID: 23485538
[TBL] [Abstract][Full Text] [Related]
37. Can proliferation signal inhibitor-induced Tregs really reflect transplantation tolerance in clinical solid organ transplantation?
Li S; Kuang A; Huang R
Int Rev Immunol; 2009; 28(5):367-75. PubMed ID: 19811315
[TBL] [Abstract][Full Text] [Related]
38. Interleukin-10 production genotype protects against acute persistent rejection after lung transplantation.
Zheng HX; Burckart GJ; McCurry K; Webber S; Ristich J; Iacono A; Dauber J; McDade K; Grgurich W; Zaldonis D; Pillage G; Griffith BP; Zeevi A
J Heart Lung Transplant; 2004 May; 23(5):541-6. PubMed ID: 15135368
[TBL] [Abstract][Full Text] [Related]
39. Cytokine gene polymorphisms predict acute graft rejection following renal transplantation.
Sankaran D; Asderakis A; Ashraf S; Roberts IS; Short CD; Dyer PA; Sinnott PJ; Hutchinson IV
Kidney Int; 1999 Jul; 56(1):281-8. PubMed ID: 10411704
[TBL] [Abstract][Full Text] [Related]
40. Cytokine gene polymorphisms and acute liver graft rejection: a meta-analysis.
Warlé MC; Metselaar HJ; Hop WC; Tilanus HW
Liver Transpl; 2005 Jan; 11(1):19-26. PubMed ID: 15690532
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]